Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

This study has been terminated.
(No satisfactory acrual)
Sponsor:
Information provided by (Responsible Party):
LOVEN DAVID, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT01067989
First received: February 11, 2010
Last updated: July 6, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)